Delivery Order SPE2DR25D3401-SPE2DR26FL0HV
- Not listed
- The Defense Logistics Agency awarded a $58,907.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Gilenya 0.5 mg capsules (30-count units) on July 14, 2025, with an ultimate completion date of July 15, 2025. This non-set-aside award is performance-based in Conshohocken, Pennsylvania, where the vendor maintains its corporate office. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $15,630.00 to AmerisourceBergen Drug Corp for the supply of Gilenya 0.5 mg capsules (quantity: 30 units) on August 12, 2025, with an ultimate completion date of August 13, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order valued at $103,162.18 to AmerisourceBergen Drug Corp for the supply of Gilenya 0.5 mg capsules (30-count units) on August 7, 2025, with completion scheduled for August 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Gilenya 0.5 mg capsules in a quantity of 30 units. This is a firm fixed price delivery order with no set-aside designation, valued at $25,513.12 and scheduled for completion by August 12, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Gilenya 0.5 mg capsules (30-count units) with a ceiling value of $20,252.06. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The order is set for ultimate completion by August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Gilenya 0.5 mg capsules (30-count) valued at $11,008.02 under a firm fixed price arrangement. The contract, which is not set-aside, is scheduled for completion by August 29, 2025, with performance based in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,000.53 to AmerisourceBergen Drug Corp for the supply of Gilenya 0.5 mg capsules (30-count units). This is a firm fixed-price, non-set-aside contract with a completion date of August 27, 2025, and represents a pediatric order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $33,570.41 to AmerisourceBergen Drug Corp for the supply of Gilenya 0.5 mg capsules (30-count units) on October 20, 2025, with an ultimate completion date of October 21, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's...
- The Defense Logistics Agency Troop Support Medical awarded a $34,008 delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division to supply 4561706120 Gilenya 0.5 mg capsules. The firm fixed price contract is for 30 capsules to be delivered to a location in Conshohocken, Pennsylvania by August 7, 2023 from a start date of August 4, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency supports Department of Defense health care...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $8,809.80 to Amerisourcebergen Drug Corporation for the supply of 4561517358 Gilenya 0.5 mg capsules, 30 count. Performance will take place at Amerisourcebergen's facility located in Conshohocken, Pennsylvania, with delivery required between July 17-18, 2023. The award was made using the prime vendor pharmaceuticals contract vehicle to fulfill pharmaceutical needs of DLA Troop Support...
- SPE2DR25D3401Indefinite Delivery Contract
- SPE2DR25D3401-SPE2DR26FL0HVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,505.56 to AmerisourceBergen Drug Corp for the supply of Gilenya 0.5 mg capsules (30-count package) on December 2, 2025, with completion scheduled for December 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Gilenya is a disease-modifying therapy used in the treatment of multiple sclerosis and represents part of the broader pharmaceutical supply chain supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement extending through December 2026 that serves as a comprehensive global pharmaceutical support vehicle. The IDC enables the contractor to supply an extensive range of medications, vaccines, and medical supplies to support Defense Health Agency operations and other federal healthcare systems worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor headquartered in Pennsylvania and maintains a significant portfolio of federal contracts across multiple therapeutic domains, demonstrating capability to meet competitive federal procurement requirements for critical medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.5k | 12/1/25 |